Replies

http://fullmeasure.news/live

Sharyll Atkisson on full measure had chuck norris and his wife talking about gaddoluinium the die that is injected into you when you get an mri.
I just had two over the past few months and had the die injected into me twice,love to know what the deal is.
Evidently there is not a lot known about the die and its hard into to find.
Tag Archives: Gadolinium Deposition Disease
VIEWPOINT CATEGORIES
Advocacy (14)
Background (19)
GBCAs (15)
NSF (3)
FDA (7)
Featured (15)
Help (20)
Getting Gadolinium Toxicity (2)
Symptoms (10)
Testing (5)
Treatment (2)
New Visitors (5)
News (58)
Pain (2)
Uncategorized (3)
RECENT VIEWPOINTS
FDA makes change to GBCA Medication Guide requirement
Head Pain is a diagnostic feature of Gadolinium Deposition Disease
Clinical Criteria for Gadolinium Deposition Disease has been revised
Revised GBCA Product Labeling with Medication Guide is now available for all agents
Preliminary report on DTPA chelation therapy to treat patients with Gadolinium Deposition Disease
CONTRIBUTORS
Hubbs G
Sharon Williams
TAGS
Adverse Events Anthropogenic Gadolinium Banned Agents Brain Fog Brain Lesions Brain Tumor Chelation Cost Cumulative Dosage D-glucose DGE MRI Disease of Degrees Dr. Richard Semelka Electric-like Sensations Erdheim-Chester Disease Europe FDA FDA Advisory Committee Meeting Funny Feelings Gadolinium Gadolinium-Associated Plaques Gadolinium-Based Contrast Agents Gadolinium Deposition Gadolinium Deposition Disease Gadolinium in Bone Gadolinium in Brain Tissue Gadolinium Retention Gadolinium Toxicity GAP GBCAs GDD Head Pain Heavy Metal Toxicity Help Henrik Thomsen Increased Signal Intensity Kidney Function Linear Agent Macrocyclic Agents Manny Kanal Mast Cell Activation Syndrome Mast Cells MCAS Medication Guide MedWatch Michael Tweedle MRI Patient Safety MRI Safety Multiple Sclerosis Normal Kidney Function Normal Renal Function NSF Pain Pediatric Case Peripheral Neuropathy Personal Stories Rash Residual Gadolinium Rocklage Scalp Lesions Sclerotic Bodies Skin Biopsy Skin Lesions Small Fiber Neuropathy Symptoms T1 Hyperintensity T1Hyperintensity Thickened Tissue Thorotrast Thyroid Gland Transmetallation Trouble Swallowing Urine testing Urine Tests Vibrating Sensation
Head Pain is a diagnostic feature of Gadolinium Deposition Disease
MAY 19, 2018 3:57 PM / 2 COMMENTS ON HEAD PAIN IS A DIAGNOSTIC FEATURE OF GADOLINIUM DEPOSITION DISEASE

On May 18, 2018, Dr. Richard Semelka added Head Pain to the recently revised primary clinical diagnostic findings for Gadolinium Deposition Disease (GDD) and he described two critical diagnostic features of GDD. First, symptoms of GDD must start within minutes to one month after administration of a gadolinium-based contrast agent (GBCA). Second, the symptoms experienced by the patient after GBCA administration must be new, and not preexisting.

There are now 6 symptoms that stand out to Dr. Semelka as critical diagnostic findings for GDD. He said that it is imperative that individuals have at least 3 of the symptoms, but he prefers to see 5/6 to be certain of the diagnosis.

The 6 main clinical criteria for Gadolinium Deposition Disease, as described by Dr. Semelka are:

1. Intense burning of the skin and skin substrate. Arising in early stage (early on after GBCA): This can be an all over feeling in the body, but often may be localized to the trunk region or distal extremities.

2. Intense boring pain in bones or joints. Arising in early stage (early on after GBCA): This can be any bones or any joints. Often the joints may be peripheral but can also be large joints like the knee or hip. Any bones can have severe point pain, but rib pain is quite distinctive for the disease.

3. Brain fog. Arising in early stage (early on after GBCA): Many terms have been used for this: mental confusion sounds more scientific, but brain fog gets the point across well and succinctly. Brain fog is also a prominent feature of lead toxicity, which is another heavy metal toxicity.

4. Muscle vibrations (muscle fasciculations) and skin pins and needles/tingling (early on after GBCA). These symptoms may represent part of the same process that is causing brain fog. Muscle vibrations/twitching and pins and needles skin sensations generally reflect nerve disease (neuropathy).

5. Head pain (early on after GBCA). Headache is both a very common occurrence and shows tremendous variability. GDD sufferers describe it as a head pain, and unlike any other type of head-ache they have previously experienced. These two properties provide differentiating features for this entity. Some describe it as a burning pain and as an extreme tightness feeling (like a tight bathing cap on their head).

6. Distal arm and leg skin/skin substrate thickening, discoloration, and pain. Arising in the subacute stage (2 weeks +): This is very much like the principal features of NSF, but generally less severe. Instead of woodiness, doughiness; instead of redness, pinkness; instead of extreme joint contractures, stiffness of joints and decreased range of motion. Skin tightness is a feature of GDD as well. This symptom complex should be expected.

https://gadoliniumtoxicity.com/tag/gadolinium-deposition-disease/
Above seems to be the problem.